Caffeine and Pregnancy

Nutrition for Mothers and Their Families

Jeff Aronin’s Paragon Biosciences Bringing World-Class Treatment Drugs to The Open

A company that brings unrecognized successful drug treatments to the right places. Paragon Biosciences has help developed treatments for over seven types of health conditions including sleep disorders and skin conditions. The company searches for solutions to insoluble health conditions and helps establish the source’s treatments into products available to the public. Narcolepsy and Alzheimer are two of the most complex medical conditions in the world. Paragon Biosciences recognizes the urge for any valuable treatments in those specialties.

Some Paragon companies including those withstanding in narcolepsy and Alzheimer research are Castle Creek Pharma, Harmony Biosciences, Precision BP, and Decade Pharmaceuticals. Paragon Biosciences partners with pharmaceutical and research companies, previously seen underground to bring their practices to life. Medical Breakthroughs require the most renowned and experienced leadership and the team out of companies re-positioning medical solutions. Paragon Biosciences’ CEO and founder, Jeff Aronin is previous CEO and founder of Ovation Pharmaceuticals Inc., a pharmaceutical company with one of the most advanced drug development technologies in the industry. Ovation ran the surface on what Aronin hope to achieve with his leadership and entrepreneurial skills inside healthcare. After Ovation’s sale in 2009, Aronin was refocused on finding more companies like his who have masterful health solutions but unable to produce commercially. His determination launched Paragon Biosciences in 2010.

Since then, Aronin is held as a pharmaceutical expert, including by one of the biggest market cities in the world. Aronin serves as a board member in World Business Chicago, a city council led enterprise for outstanding business development ( Aronin also founded MATTER in Chicago, a smaller version of Paragon, that brings light to healthcare development inside small communities and start-ups. All of Aronin’s measures have paid off shortly. 13 of the drugs developed under Paragon have already been granted approval by the FDA. Jeff Aronin is an Illinois native, attending Northern Illinois University, and later DePaul University to receive his MBA. Paragon’s based off Chicago, with now offices in New Jersey and Philadelphia.



Leave a Reply